Anti-retroviral drugs during breast-feeding cut HIV transmission

04/26/2012 | PhysiciansBriefing.com

The cumulative risk of HIV-1 mother-to-infant transmission at 48 weeks was significantly lower among breast-feeding HIV-positive mothers who received anti-retroviral drugs or whose infants received anti-retroviral drugs, CDC researchers wrote in the journal The Lancet. The trial in Malawi also found a greater risk of diarrhea, delayed growth, malaria, tuberculosis and death in infants after weaning by 28 weeks.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC